Clinical trial
Mesalazine Treatment in IBS, a Double-blind Placebo-controlled Phase II Intervention Study in Adult Patients
NCT01699438 is registered in ClinicalTrials.gov with Hans Törnblom as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesalazine Treatment in IBS, a Double-blind Placebo-controlled Phase II Intervention Study in Adult Patients
- Lead sponsor
- Hans Törnblom
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- February 28, 2017
- Enrollment
- 211 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.